Total number:60 | Variables | |||
---|---|---|---|---|
6 (10%) | Hepato biliary system anomaly | |||
4(6.6%) | Choledocal cyst | |||
1 (1.7%) | Common bile duct stone | |||
1(1.7%) | Pancreatic duct stenosis | |||
6 (10%): | Infectious disease | |||
1 (1.7%) | Urinary tract infection | |||
1(1.7%) | Upper respiratory tract infection | |||
1(1.7%) | Spontaneous bacterial peritonitis (SBP) | |||
2 (3.3%) | Pneumonia | |||
1(1.7%) | Covid-19 infection (positive PCR) | |||
13 (21%) | Systemic disease | |||
5 (8.3%) | Hyperlipidemia | |||
2 (3.3%) | Minor thalassemia | |||
1(1.7%) | Systemic lupus erythematosus | |||
1 (1.7%) | Hypothyroidism | |||
1(1.7%) | End stage renal disease | |||
1 (1.7%) | Metabolic disease | |||
1 (1.7%) | Cystic fibrosis | |||
1(1.7%) | Diabetes mellitus | |||
5(8.3%) | Trauma history | |||
3(5%) | Blunt trauma | |||
2(3%) | Post-surgery | |||
8(13.3%) | Drugs associated with acute pancreatitis | |||
3 (5%) | Sodium valproate | |||
4(6.6%) | Corticosteroid | |||
4(6.6%) | Carbamazepine + sodium valproate |